Furthermore, it has recently been shown that pharmacologic ascorbate kills colorectal cancer cells depending on the KRAS mutational status [64], and it impairs the Warburg effect by resulting in the downregulation of both GLUT1- and PKM2-dependent protein expression [24]. The gene discussed is KRAS; the disease is colorectal cancer.